Infusions reduce lead levels but show no effect on clinical endpoints
April 08, 2024
Chelation Therapy Does Not Improve Outcomes after Heart Attack
April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-…
Read More
Study suggests routine use is likely unnecessary for those with normal ejection fraction
April 08, 2024
Beta Blockers May Not Benefit Many Heart Attack Survivors
April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second…
Read More
Mechanical circulatory support boosts survival in cardiogenic shock patients, despite risks
April 08, 2024
Heart Pump Improves Survival After Severe Heart Attacks
April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly…
Read More
Ticagrelor alone outperforms 12-month DAPT for reducing bleeding with no increased risk
April 08, 2024
Study Suggests Most Patients with Acute Coronary Syndromes Can Safely Stop Aspirin One Month After Percutaneous Coronary Intervention
April 8, 2024 — People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin…
Read More
Earning points or small sums of money encourages people to ‘step up’ their physical activity
April 07, 2024
Incentives Prompt Increased Daily Walking in Patients at Risk for Heart Disease
April 7, 2024 — Strategies such as earning points or small amounts of money encouraged people at high risk for heart…
Read More
When added to standard blood pressure medication, new drug could minimize the need for pills and reduce cardiovascular risks
April 07, 2024
One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg
April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing…
Read More
Results show drug is effective and safe, leaves open question of optimal dosing
April 07, 2024
Study Finds Olezarsen Cuts Triglyceride Levels by About Half
April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated…
Read More
90% of high-risk patients on lerodalcibep achieved guideline-recommended cholesterol targets
April 07, 2024
Novel PCSK9 Inhibitor Cut LDL Cholesterol Levels by More Than Half
April 7, 2024 — Among patients at high or very high risk for a heart attack or stroke, the addition of the…
Read More
Novel drug shows promise for treating severe hypertriglyceridemia in patients at high risk for pancreatitis
April 07, 2024
Plozasiran Reduces Triglyceride Levels by 74% at 24 Weeks
April 7, 2024 — In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the…
Read More
Study shows no benefit for heart failure overall but suggests different effects in those with preserved versus reduced ejection fraction
April 06, 2024
RELIEVE-HF Trial Outcomes Reported at ACC.24 Find Impact of Interatrial Shunt May Vary by Heart Failure Type
April 6, 2024 — Patients with heart failure who had a small shunt inserted between the heart’s left and right atria did…
Read More
While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack
April 06, 2024
EMPACT-MI Trial Outcomes Reported at ACC.24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack
April 6, 2024 — Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did…
Read More
Exploratory analysis finds beneficial effect on patient outcomes at one year, according to a study presented at ACC.24.
April 06, 2024
Research Presented at ACC 2024 Found No Reduction in 90-Day Deaths, Heart Attacks With Human Apo/A1
April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the…
Read More
The Minneapolis Heart Institute Foundation (MHIF) is presenting data on trends in ST-elevation myocardial infarction (STEMI) at the American College of Cardiology’s Annual Scientific Session (ACC.24). An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovascular disease.
April 06, 2024
Research Data from Minneapolis Heart Institute Foundation at ACC 2024 Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks
April 6, 2024 — The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in…
Read More
Smidt Heart Institute experts will be available for media interviews throughout ACC.24.
April 06, 2024
ACC.24: Smidt Heart Institute Experts to Share Research Findings, Clinical Knowledge
April 6, 2024 — Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more…
Read More
Registration is open for a leading conference on structural heart disease announced by the Cardiovascular Research Foundation, CRF.
April 05, 2024
Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit
April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit…
Read More
Cardiawave SA will present the 30-day follow-up results for 60 patients enrolled in its European pivotal study to the 73rd annual conference of the American College of Cardiology in Atlanta, Georgia
April 05, 2024
Cardiawave is Presenting the 30-day Follow-up Results from its “Valvosoft Pivotal Study” on the Teatment of Severe Symptomatic Aortic Valve Stenosis at ACC24
April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused…
Read More
The acquisition enhances Johnson and Johnson’s ability to transform the treatment landscape for cardiovascular disease and continue to improve patient outcomes
April 05, 2024
Johnson and Johnson to Acquire Shockwave Medical
April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a…
Read More
Viz.ai will be announced new clinical data supporting advancements in cardiology care during the American College of Cardiology Scientific Sessions, ACC.24
April 04, 2024
Real-world Evidence at the American College of Cardiology Scientific Session ACC.24 to Demonstrate Positive Impact of Viz.ai on Suspected Disease Detection and Patient Triage for Improved Care
April 4, 2024 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced new…
Read More
Virtual Reality Simulation Company Collaborates with American College of Cardiology to Help Cardiovascular Clinicians Immersively Practice Clinical Procedures
April 04, 2024
Osso VR Expands Cardiology Training through ACC Collaboration
April 4, 2024 — Osso VR, a leader in immersive procedural training, announces the release of a co-developed curriculum…
Read More
Early coronary disease and impaired heart function, with increased coronary vessel wall thickness, in asymptomatic, middle-aged individuals living with HIV has been reported in a new study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).
April 04, 2024
New Study Finds Early Coronary Disease, Impaired Heart Function in Asymptomatic People with HIV
April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now